Neuromultivit (Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride)

Thiamine, pyridoxine and cyanocobalamin each act as essential co‑enzymes. Thiamine supports carbohydrate breakdown, pyridoxine assists amino‑acid metabolism and neurotransmitter synthesis, and cyanocobalamin is required for DNA synthesis and red blood cell production. Together they restore normal metabolic processes.

The dosage of Neuromultivit is determined by the prescribing clinician based on the patient’s age, weight, severity of deficiency and clinical response. Healthcare professionals set the appropriate intramuscular volume and frequency for each individual case.

Neuromultivit contains vitamins that are generally considered safe, but pregnant or lactating individuals should only use it under medical supervision. A healthcare provider will evaluate the benefits and any potential risks before recommending treatment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Neuromultivit delivers a combined B1, B6 and B12 formulation in a single intramuscular injection, offering rapid bioavailability compared with oral tablets that may have variable absorption. It is particularly useful when oral intake is limited or when a quick correction of deficiency is required.

Neuromultivit should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the vial. If the product reaches room temperature for an extended period, discard it and obtain a new supply.

Neuromultivit is given by intramuscular injection, typically into the deltoid or gluteal muscle. Administration should be performed by a qualified healthcare professional using aseptic technique, following the dosage prescribed by the treating clinician.

Serious risks include severe allergic reactions such as anaphylaxis, persistent hypotension, and rare cases of acute hemolysis. Patients should be monitored after injection for any signs of hypersensitivity or unexpected systemic effects.

Neuromultivit should be avoided in individuals with known hypersensitivity to any of its B‑vitamin components, in patients with severe renal impairment without medical supervision, and in anyone for whom the prescriber determines that the risks outweigh the benefits.